Floatz logo

(±)-Ftc

HIV Infectious Disease

José Antonio Mata MarínSmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
81/ 100

Competitive context

58 Active assets in the HIV Infectious Disease cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
Efavirenz
The Cleveland Clinic
Phase 4BBB
Retrovir
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Abacavir
Germans Trias i Pujol Hospital
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 46 →

Same molecule, other indications

(±)-Ftc is also rated in:

mixed anxiety and depressive disorderDormant
BB
Indicative · Phase 4
66 / 100
View asset →
fatty liver diseaseActive
BB
Indicative · Phase 4
66 / 100
View asset →
sleep disorder, initiating and maintaining sleepDormant
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →